DYAI
DYADIC INTERNATIONAL INC
NASDAQ · Healthcare · Biotechnology · US
$0.42
−2.05%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.03
- Revenue estimate
- $1.4M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.06
- EPS estimate
- -$0.04
- Revenue actual
- $961.1K
- Revenue estimate
- $1.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -61.6%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.04 | -$0.06 | Miss -71.43% | $961.1K |
| May 13, 2026 | -$0.04 | -$0.05 | Miss -25.00% | $1.1M |
| Mar 25, 2026 | -$0.03 | -$0.06 | Miss -100.00% | $564.3K |
| Nov 12, 2025 | -$0.04 | -$0.06 | Miss -50.00% | $1.2M |
| Aug 13, 2025 | -$0.06 | -$0.06 | In line | $463.4K |
| May 14, 2025 | — | -$0.07 | — | $393.6K |
| Mar 26, 2025 | -$0.04 | -$0.05 | Miss -25.00% | $817.4K |
| Nov 10, 2022 | -$0.10 | -$0.06 | Beat 40.00% | $879.6K |
| Aug 10, 2022 | -$0.09 | -$0.12 | Miss -33.33% | $658.6K |
| May 12, 2022 | -$0.09 | -$0.09 | In line | $648.4K |
| Nov 10, 2021 | -$0.10 | -$0.06 | Beat 40.00% | $692.9K |
| Aug 12, 2021 | -$0.09 | -$0.14 | Miss -55.56% | $937.1K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026